Substance use disorders (SUDs) are a major social concern in the United States and other developed countries. There is an extensive economic literature estimating the social costs associated with SUDs in terms of healthcare, labor market outcomes, crime, traffic accidents, and so forth. However,...

Each year, approximately 10,000 individuals die in alcohol-impaired traffic crashes in the United States, while psychoactive drugs are involved in 20% of all fatal traffic crashes. In this study, we investigate whether state-specific parity laws for substance use disorder (SUD) treatment have...

We examine how substance use disorder (SUD) treatment providers respond to private insurance expansions induced by state equal coverage (‘parity') laws for SUD treatment vis-à-vis general healthcare services. Economic theory suggests that such laws will lead to changes in provider behaviors....

We provide the first evidence on the effects of expansions to private and public insurance programs on children’s use of specialty substance use disorder (SUD) treatment. We combine administrative government data over the period 1996 to 2017 with quasi-experimental differences-in-differences...

We examine Medicaid expansion under the Affordable Care Act (ACA) on substance use disorder (SUD) treatment utilization and financing. We couple administrative data on admissions to specialty SUD treatment and prescriptions for medications used to treat SUDs with a differences-in-differences...